Table 4.
Relationships between F-NLR and 5-year OS in patients undergoing curative resection for stage I–III GC
| Characteristics | TNM stage I
|
TNM stage II
|
TNM stage III
|
TNM stages I–III
|
||||
|---|---|---|---|---|---|---|---|---|
| n | 5-year OS | n | 5-year OS | n | 5-year OS | n | 5-year OS | |
| F-NLR | 218 | 92 (2) | 322 | 74 (3) | 753 | 37 (2) | 1293 | 56 (2) |
| 0 | 195 | 93 (2) | 249 | 80 (3) | 542 | 41 (2) | 986 | 61 (2) |
| 1 | 23 | 89 (8) | 66 | 53 (8) | 190 | 32 (4) | 279 | 42 (4) |
| 2 | 0 | NA | 7 | 44 (2) | 21 | 6 (6) | 28 | 15 (8) |
Notes: The values are expressed as n or percentage (standard error). Survival is not calculated if n≤10. F-NLR, combination of fibrinogen and the NLR.
Abbreviations: GC, gastric cancer; NA, not applicable; NLR, neutrophil–lymphocyte ratio; OS, overall survival.